PS3-6: Blood Safety Continuous Active-Surveillance Network Feasibility Evaluation (Blood-SCAN)

BACKGROUND/AIMS: In 2011, the US Food and Drug Administration (FDA) created the Blood Safety Continuous Active-Surveillance Network (Blood-SCAN), the first nationwide active surveillance system for monitoring the safety of FDA-regulated blood components and blood-derived products. Blood-SCAN employs...

Full description

Saved in:
Bibliographic Details
Main Authors: Baker, Meghan, Nguyen, Michael, Mullersman, Jerald, Lauer, Jillian, Zinderman, Craig, Riedlinger, Karen, Nakasato, Cynthia, Chrischilles, Elizabeth, Garcia, Crystal, Balsbaugh, Carolyn, Vajani, Madhavi
Format: Artigo
Language:Inglês
Published: Marshfield Clinic 2013
Subjects:
Selected Abstracts-HMORN 2013: Pharmacoepidemiology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3788538/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2013.1176.ps3-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items